Home » CytoCore Signs Agreement to Sell Synermed’s General Cytology Preservative
CytoCore Signs Agreement to Sell Synermed’s General Cytology Preservative
CytoCore, Inc., the developer of cost-effective products used for the detection of cancerous and precancerous conditions and privately held Synermed Select Partners … announced a distribution agreement that gives CytoCore US and international rights to distribute the Synermed General Cytology Preservative in combination with its SoftPAP cervical cell collection device.
TradingMarkets
TradingMarkets
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May